clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
Combining Blood Test with Clinical Score Offers Breakthrough for Stroke Detection
News & Features
New Protein Marker Identified for Breast Cancer Prognosis
Molecular Dx
Cord Blood Proteomic Profile May Help Predict Baby Growth Trajectories
News & Features
AI Could Automate Oropharyngeal Cancer Staging
News & Features
Can New Biomarker Data Improve Cardiovascular Risk Assessment?
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Metsera Launches with $290M to Develop Next Generation Weight Loss Products
Antidiabetic agents
News & Features
Metsera Launches with $290M to Develop Next Generation Weight Loss Products
Malorye Branca
-
April 22, 2024
0
News & Features
Weight Loss Drugs Linked to Lower Rate of Multiple Sclerosis
Malorye Branca
-
April 16, 2024
0
News & Features
Scandinavian Study Clears GLP-1 Agonists of Thyroid Cancer Risk
Alisa Kirkin
-
April 11, 2024
0
News & Features
Weekly Semaglutide Injection Reduces Liver Disease Severity in People with HIV
Chris Anderson
-
March 6, 2024
0
News & Features
Semaglutide Cuts Death by Quarter among Diabetics with Kidney Disease
Malorye Branca
-
March 5, 2024
0
News & Features
Bone Formation Protein Protective of Cardiovascular Health in Patients with Type 2 Diabetes
Chris Anderson
-
January 29, 2024
0
News & Features
Insulin Delivered via Nano-Carriers May Pave Way for Oral Diabetes Treatment
Chris Anderson
-
January 22, 2024
0
News & Features
Kidney Disease Drug Candidate Shows Broad Inhibition of Damaging Hormone
Chris Anderson
-
December 18, 2023
0
News & Features
Class of Diabetes Drugs May Prevent Development of Colorectal Cancer
Chris Anderson
-
December 8, 2023
0
News & Features
In Potential $2B Deal, AstraZeneca Licenses Oral GLP-1 Agonist for Weight Loss
Malorye Branca
-
November 9, 2023
0
1
2
3
Page 1 of 3
Related Content
Dual-Action Drug Spurs Twice the Weight Loss in Mice as GLP-1 Agonist Alone
Zenas Nets $200M to Advance mAb for Autoimmune Diseases
New Treatment Target for Age-Related Macular Degeneration Discovered
Enlaza Nets $100M to Advance Covalent Biologics Platform
Inside Precision Medicine